A Phase I Dose Escalation Study Of TGR-1202, a Novel PI3K-I´ Inhibitor, For Patients With Relapsed Or Refractory Hematologic Malignancies »
04/05/14

Clonal Evolution and Therapy Related Selection Of TP53 Mutations In Chronic Lymphocytic Leukemia Patients »
04/05/14

Kinetics Of Chronic Lymphocytic Leukemia Cells In Tissues and Blood During Therapy With The BTK Inhibitor Ibrutinib »
04/05/14

CXCR4 Upregulation Is a Biomarker Of Sensitivity To Targeted Inhibition Of B-Cell Receptor Signaling In Diffuse Large B-Cell Lymphoma »
04/05/14

Apparent Involvement Of The Interferon, RNA Processing, and Wnt Signaling Pathways In Monoclonal B Lymphocytosis. »
04/05/14

A Novel Cyclin Dependent Kinase (CDK) Inhibitor P1446A Induces Apoptosis Of Chronic Lymphocytic Leukemia B Cells »
04/05/14

Targeting Chronic Lymphocytic Leukemia With DNA Nanoparticles »
04/05/14

The BCL2 Targeted Deoxyribonucleic Acid Inhibitor (DNAi) PNT2258 Is Active In Patients With Relapsed Or Refractory Non-Hodgkina€™s Lymphoma »
04/05/14

TCL1 Expression Pattern and Its Prognostic Impact In WaldenstrA¶ma€™s Macroglobulinemia »
04/05/14

Unrelated Umbilical Cord Blood Transplantation: Characteristics and Outcomes In Older Patients With Hematological Malignancies In Europe and United States: A Eurocord/European Group For Blood and Marrow Transplantation (EBMT) and Center For International Blood and Marrow Transplant Research (CIBMTR) Study »
04/05/14